Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism.
B. Lindholm,R. Hand,A. Saxena,Ángeles Espinosa-Cuevas,S. Sezer,P. T. ter Wee,T. Ikizler,A. Hung,A. Cordeiro,J. Carrero,Hong Xu,K. Kalantar-Zadeh,Yimin Lu,A. Wang,P. Marckmann,T. Karupaiah,Fridtjof Thomas,D. Mafra,C. Avesani,L. Johansson,Jongha Park,Maria Chan,E. Fiaccadori,S. Russo,F. Guebre-egziabher,F. Arogundade,Kristóf Nagy,D. Teta,Cecile Verseput,C. Kovesdy,M. Molnar,R. Parekh,M. Chmielewski
DOI: https://doi.org/10.1053/j.jrn.2018.08.006
IF: 4.354
2018-11-01
Journal of Renal Nutrition
Abstract:OBJECTIVE
To better define the prevalence of protein-energy wasting (PEW) in kidney disease is poorly defined.
METHODS
We performed a meta-analysis of PEW prevalence from contemporary studies including more than 50 subjects with kidney disease, published during 2000-2014 and reporting on PEW prevalence by subjective global assessment or malnutrition-inflammation score. Data were reviewed throughout different strata: (1) acute kidney injury (AKI), (2) pediatric chronic kidney disease (CKD), (3) nondialyzed CKD 3-5, (4) maintenance dialysis, and (5) subjects undergoing kidney transplantation (Tx). Sample size, period of publication, reporting quality, methods, dialysis technique, country, geographical region, and gross national income were a priori considered factors influencing between-study variability.
RESULTS
Two studies including 189 AKI patients reported a PEW prevalence of 60% and 82%. Five studies including 1776 patients with CKD stages 3-5 reported PEW prevalence ranging from 11% to 54%. Finally, 90 studies from 34 countries including 16,434 patients on maintenance dialysis were identified. The 25th-75th percentiles range in PEW prevalence among dialysis studies was 28-54%. Large variation in PEW prevalence across studies remained even when accounting for moderators. Mixed-effects meta-regression identified geographical region as the only significant moderator explaining 23% of the observed data heterogeneity. Finally, two studies including 1067 Tx patients reported a PEW prevalence of 28% and 52%, and no studies recruiting pediatric CKD patients were identified.
CONCLUSION
By providing evidence-based ranges of PEW prevalence, we conclude that PEW is a common phenomenon across the spectrum of AKI and CKD. This, together with the well-documented impact of PEW on patient outcomes, justifies the need for increased medical attention.
Medicine